Skip to content

LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial

LUcas Continuous Chest Compressions in Out-of-hospital Cardiac Arrest Treatment. The LUCAT Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01521208
Acronym
LUCAT
Enrollment
400
Registered
2012-01-30
Start date
2012-01-31
Completion date
2014-04-30
Last updated
2012-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Cardiac Arrest

Keywords

Out-of-Hospital cardiac arrest (OHCA), Chest compressions, LUCAS device

Brief summary

The goal of this study is to show the superiority in survival at hospital admittance and in neurological outcome on hospital discharge of continuous mechanical chest compression using LUCAS device versus manual chest compressions in patients who suffered an out-of-hospital cardiac arrest.

Detailed description

The primary goals of the trial are: * To show a survival increase at hospital admittance after out-of-hospital cardiac arrest of patients treated by continuous chest compressions LUCAS device compared with patients treated by manual chest compressions. * To evaluate neurological outcome on hospital discharge, in two centres (Vall d'Hebron Hospital and Josep Trueta Hospital).

Interventions

DEVICELUCAS (Lund University Cardiac Assist Sysrem)

LUCAS device will be placed on patients suffering a cardiac arrest and continuous chest compressions will be performed, even while defibrillation is being applied

Manual CPR according to 2010 ERC guidelines will be performed

Sponsors

Hospital Vall d'Hebron
CollaboratorOTHER
Sistema d'Emergències Mèdiques
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: between 18 and 80 years , * Suffering from NON traumatic or an unexpected SCA, * SCA witnessed (seen, heard or monitored), * Attended by an advanced support ambulance (served by doctor or nurse) in Barcelona city, or in the Girona or Lleida area * Time between alarm-call to SEM 061 and reaching patient is less than 12 minutes.

Exclusion criteria

* Biological signs of death * Age under 18 or over 80 years * Trauma caused cardio respiratory arrest (CRA), including hanging * Secondary CRA or intoxication * Return of spontaneous circulation previous to arrival of SEM's medical team * Known pregnancy * Inadequate size for LUCAS device * Anything in the study that can delay treatment

Design outcomes

Primary

MeasureTime frameDescription
Survival at hospital admittance2 hoursThe primary goal is to evaluate survival at hospital admittance of patients, after out-of hospital cardiac arrest treated by LUCAS device chest compressions, compared with those patients treated by manual chest compressions
Survival on discharge from hospital (or 30 days if not applicable) in acceptable neurological state (CPC scale 1 or 2)30 daysEvaluate the neurological outcome on hospital discharge, in two centres (Vall d'Hebron Hospital in Barcelona and Josep Trueta Hospital in Girona) 1 or 2 in Cerebral Performance Category

Secondary

MeasureTime frameDescription
SOFA scale valuesDuring the first three days and on hospital dischargeTo compare the first three days, on hospital discharge SOFA scale value and the worse value obtained (date and hour) in patients who survived out-of-hospital SCA and weere brought to either Vall d'Hebron Hospital or Josep Trueta Hospital.
Days before discharge from Intensive Care Unit (ICU) / Coronary Care Unit (CCU)30 daysTo compare days before discharge from Intensive Care Unit (ICU) / Coronary Care Unit (CCU) in patients who survived out-of-hospital SCA and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital
Metabolic (pH, lactate) and inflamatory (leukocytes, C reactive protein) parametersDuring the first 24h, at >48h and at 5-7daysTo establish the differences in metabolic (pH, lactate) and inflamatory (leukocytes, C reactive protein) parameters in patients who survived out-of-hospital SCA and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital
Restoration of spontaneous circulation2 hoursTo compare the return of spontaneous circulation (ROSC) between both groups
To obtain a blood sample for genetic and biological studies7 daysBlood samples from SCA survivors will be kept to perform biological studies.
Left ventricular functionDuring the first 24h and during the 24h previous on hospital discharge or at two monthsTo compare left ventricular function in patients who survived at out-of-hospital sudden cardiac arrest and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital
Epidemiology of Out-of-Hospital Cardiac Arrest3 monthsTo describe the epidemiology of out-of-hospital SCA in the cities of Barcelona, Girona and Lleida
EndTidal CO2 valuesEvery four minutes during resuscitation maneuversTo compare EndTidal CO2 values of patients during cardiopulmonary resuscitation (CPR)between boths study arms

Countries

Spain

Contacts

Primary ContactFrancesc Carmona Jiménez, Doctor
franciscojosecarmona@gencat.cat+34607847717
Backup ContactRosa-Maria Lidón, Doctor
rmlidon@vhebron.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026